P-087 - EARLY EVALUATION OF PSA KINETICS IN M-HSPC TREATED WITH APALUTAMIDE
P-088 - Early experience in parciaI irradiation with IORT in one institution
P-089 - EARLY EXPERIENCE WITH PSMA/PET IN BIOCHEMICAL RECURRENCE OF PROSTATE CANCER
P-090 - EARLY TOXICITY USING FAST FORWARD PROTOCOL AT TERTIARY HOSPITAL
P-091 - Superficial radiotherapy as a treatment option on early-stage Basal Cell Skin Cancer and Squamous Skin Cancer. A retrospective review in our institution with a unique treatment scheme.
P-092 - EFFICACY AND SAFETY OF ALANTELĀ®-CREAM IN IRRADIATION OF BREAST CANCER
P-093 - EFFICACY AND TOXICITY OF APALUTAMIDE IN METASTATIC-PROSTATE CANCER: OUR EXPERIENCE
P-094 - Electronic brachytherapy in non-melanoma skin cancer
P-096 - EQUITY OF ACCESS TO BREAST INTRAOPERATIVE RADIOTHERAPY IN OUR COMMUNITY
P-097 - EVALUATING LOCAL RESPONSE TO RADIOIMMUNOTHERAPY IN METASTATIC MELANOMA
P-098 - EVALUATING RADIOTHERAPY IMPACT IN OSTHEOARTICULAR DEGENERATIVE DISORDERS
P-099 - EVALUATION OF A MANAGEMENT MODEL FOR RADIOTHERAPY INTERRUPTIONS
P-100 - EVALUATION OF EXTREME HYPOFRACTIONATED RADIATION THERAPY IN EARLY BREAST CANCER.
P-101 - EVALUATION OF FRAILTY IN ELDERLY PATIENTS.
P-102 - EVALUATION OF RESPONSE WITH PET-TC AFTER SCRT IN RECTAL CANCER
P-103 - EVALUATION OF RESPONSE TO RADIOCHEMOTHERAPY-BASED TREATMENT USING IMAGING FEATURES
P-104 - EVALUATION OF THE EFFECTIVENESS OF SHORT-COURSE NEOADJUVANT RADIOTHERAPY IN LARC.
P-105 - EVALUATION OF TOXICITY SECONDARY TO INTRAOPERATIVE RADIOTHERAPY FOR BREAST CANCER
P-106 - EVOLUTION OF FRAILTY IN RADIOTHERAPY
P-107 - EVOLUTION OF SURVIVAL IN BRAIN METASTATIC PATIENTS TREATED WITH RADIOSURGERY
P-108 - EXPERIENCE IN ELECTRON INTRAOPERATIVE RADIATION THERAPY IN ONE CENTER